8 hasil untuk "Simon R Procter"
Menampilkan 1–8 · 0,20 detik · RSS
-
Artikel Jurnal Teks lengkap
paramix : An R package for parameter discretisation in compartmental models, with application to calculating years of life lost
Compartmental infectious disease models are used to calculate disease transmission, estimate underlying rates, forecast future burden, and compare benefits across intervention scenarios. These models aggregate individuals into compartments, often stratified by characteristics to represent groups…
-
Artikel Jurnal Teks lengkap
Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods
Neonatal invasive disease caused by Group B Streptococcus (GBS) is responsible for much acute mortality and long-term morbidity. To guide development of better prevention strategies, including maternal vaccines that protect neonates against GBS, it is necessary to estimate the burden of this…
-
Artikel Jurnal Teks lengkap
The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study
Background: Maternal respiratory syncytial virus (RSV) vaccine, RSV prefusion F protein vaccine (RSVpreF (Abrysvo)), was found to be safe and efficacious in the MATISSE trial. However, post-hoc stratified analyses identified an excess of preterm births in the intervention arm in two…
-
Artikel Jurnal Teks lengkap
Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness
…at reasonable prices is likely to be a cost-effective intervention. Simon R Procter and colleagues explore the global health impact and cost-effectiveness of maternal immunisation against Group B Streptococcus. Why was this study done?: What did the researchers do and find?: What do these findings…
-
Artikel Jurnal Teks lengkap
What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria
While safe and efficacious COVID-19 vaccines have achieved high coverage in high-income settings, roll-out remains slow in sub-Saharan Africa. By April 2022, Nigeria, a country of over 200 million people, had only distributed 34 million doses. To ensure the optimal use of health resources…
-
Artikel Jurnal Teks lengkap
COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness
Background: Multiple Coronavirus Disease 2019 (COVID-19) vaccines appear to be safe and efficacious, but only high-income countries have the resources to procure sufficient vaccine doses for most of their eligible populations. The World Health Organization has published guidelines for vaccine…
-
Artikel Jurnal Teks lengkap
The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysis
Background: Next-generation influenza vaccines (NGIVs) are in development and have the potential to achieve substantial reductions in influenza burden, with resulting widespread health and economic benefits. The prices at which their market can be sustained and which vaccination strategies may…